Suppr超能文献

微小RNA-122通过PI3K/AKT信号通路对鼻咽癌细胞发挥抗增殖和促凋亡作用。

MiR-122 exerts anti-proliferative and apoptotic effects on nasopharyngeal carcinoma cells via the PI3K/AKT signaling pathway.

作者信息

Cheng Chen, Xiaohua Wang, Ning Jiang, Dan Zong, Chengyun Yao, Lijun Zhao, Li Yin, Shengfu Huang, Hong Ji, He Xia

机构信息

Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.

Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.

出版信息

Cell Mol Biol (Noisy-le-grand). 2018 Oct 30;64(13):21-25.

Abstract

To investigate the effects of microRNA-122 (miR-122) on the proliferation and apoptosis of nasopharyngeal carcinoma (NPC) HONE-1 cells, and its correlation with the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. Human NPC cell line (HONE-1) was transfected with miR-122 inhibitor (anti-miR-122 group), negative controls (vector control group) via lipofectamines, and HONE-1 cell lines undergoing no transfection were selected (non-transfection group). The expression of miR-122, cell proliferation, apoptosis, and expressions of PI3K/AKT pathway and downstream target proteins in the three groups were determined using fluorescence quantitative polymerase chain reaction (qPCR), cell counting kit-8 (CCK8), immunofluorescence (IF) and Western blotting, respectively. The expression of miR-122 in the anti-miR-122 group was significantly lower than corresponding expressions in the non-transfection and vector control groups after 48h of transfection (p <0.05). The proliferation of cells in the anti-miR-122 group was significantly reduced with time after transfection (p <0.05). After 48h of transfection, the extent of apoptosis in the anti-miR-122 group (47.11 ± 1.95%) was significantly higher than that in normal control (7.37 ± 0.82%) and vector control group (8.54 ± 0.96%; p <0.05). There were no significant differences in the expressions of PI3K, AKT, mTOR protein, and the downstream signal proteins (p70S6K and 4E-BP1) in the three groups (p >0.05). However, the expressions of phosphorylated forms of these proteins were significantly lower in the anti-miR-122 group than in the non-transfection and vector control groups (p <0.05). IF results revealed that there were no significant differences in the fluorescence intensity value of PI3K and Akt among the three groups of patients (p>0.05). Inhibition of the expression of miR-122 in NPC suppresses the proliferation, and promotes their apoptosis through the PI3K/AKT signal transduction pathway.

摘要

探讨微小RNA-122(miR-122)对鼻咽癌(NPC)HONE-1细胞增殖和凋亡的影响及其与磷酸肌醇3-激酶(PI3K)/蛋白激酶B(Akt)信号通路的相关性。采用脂质体分别将miR-122抑制剂转染人NPC细胞系(HONE-1)(抗miR-122组)、阴性对照(载体对照组),选取未转染的HONE-1细胞系(未转染组)。分别采用荧光定量聚合酶链反应(qPCR)、细胞计数试剂盒-8(CCK8)、免疫荧光(IF)和蛋白质免疫印迹法检测三组中miR-122的表达、细胞增殖、凋亡以及PI3K/AKT通路及其下游靶蛋白的表达。转染48h后,抗miR-122组中miR-122的表达显著低于未转染组和载体对照组(p<0.05)。转染后抗miR-122组细胞增殖随时间显著降低(p<0.05)。转染48h后,抗miR-122组的凋亡率(47.11±1.95%)显著高于正常对照组(7.37±0.82%)和载体对照组(8.54±0.96%;p<0.05)。三组中PI3K、Akt、mTOR蛋白及下游信号蛋白(p70S6K和4E-BP1)的表达无显著差异(p>0.05)。然而,抗miR-122组中这些蛋白的磷酸化形式表达显著低于未转染组和载体对照组(p<0.05)。IF结果显示,三组患者PI3K和Akt的荧光强度值无显著差异(p>0.05)。抑制NPC中miR-122的表达可抑制其增殖,并通过PI3K/AKT信号转导通路促进其凋亡。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验